دورية أكاديمية
أعرض في EDS

Telehealth and Telemedicine in Latin American Rheumatology, a New Era After COVID-19.

التفاصيل البيبلوغرافية
العنوان: Telehealth and Telemedicine in Latin American Rheumatology, a New Era After COVID-19.
المؤلفون: Graf C; From the Instituto Medico Mitre, Parana, Entre Rios, Argentina., Fernández-Ávila DG; Unidad de Reumatología, Pontificia Universidad Javeriana-Hospital Universitario San Ignacio, Bogotá, Colombia., Plazzotta F; Department of Health Informatics., Soriano ER
المصدر: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2023 Apr 01; Vol. 29 (3), pp. 165-169.
نوع المنشور: Review; Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9518034 Publication Model: Print Cited Medium: Internet ISSN: 1536-7355 (Electronic) Linking ISSN: 10761608 NLM ISO Abbreviation: J Clin Rheumatol Subsets: MEDLINE
أسماء مطبوعة: Publication: Philadelphia, PA : Lippincott Williams & Wilkins
Original Publication: Baltimore, MD : Williams & Wilkins, c1995-
مواضيع طبية MeSH: COVID-19* , Rheumatology* , Telemedicine*, Humans ; Latin America/epidemiology ; SARS-CoV-2
مستخلص: Abstract: Telemedicine is the delivery of health care services by health care professionals using information and communication technologies to exchange valid information for the diagnosis, treatment, and prevention of diseases. Telemedicine was further developed in Latin America during the COVID-19 (coronavirus disease 2019) pandemic, becoming the first line of defense for health professionals to stop the spread of infections and allow them to continue the care of their patients. During the pandemic, 79% of rheumatologists in Latin America reported the use of remote communication, the most frequent being the use of phone calls and WhatsApp voice messages. In contrast, 84% of the patients reported that telemedicine was appropriate for them during the pandemic, but only 54% considered telemedicine to be a valid option for rheumatic health care after the pandemic. Telemedicine and telehealth have advantages such as lower costs, improved access in rural areas, shortage of care providers, and reduction in waiting time for appointments. However, it also has some challenges, such as legal, technological, and organizational barriers. In this review, we explore the current state of telemedicine in Latin America and discuss its future.
Competing Interests: The authors declare no conflict of interest.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
References: World Health Organization. Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth (Global Observatory for eHealth, No. 2) . 2022nd ed. Geneva, Switzerland: World Health Organization; 2010.
Huibers L, Bech BH, Kirk UB, et al. Contacts in general practice during the COVID-19 pandemic: a register-based study. Br J Gen Pract . 2022;72:e799–e808.
Kim EJ, Kaminecki I, Gaid EA, et al. Development of a telemedicine screening program during the COVID-19 pandemic. Telemed J E Health . 2022;28:1199–1205.
Smith AC, Thomas E, Snoswell CL, et al. Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare . 2020;26:309–313.
Emmett SD, Platt A, Turner EL, et al. Mobile health school screening and telemedicine referral to improve access to specialty care in rural Alaska: a cluster-randomised controlled trial. Lancet Glob Health . 2022;10:e1023–e1033.
Muqri H, Shrivastava A, Muhtadi R, et al. The cost-effectiveness of a telemedicine screening program for diabetic retinopathy in new York City. Clin Ophthalmol . 2022;16:1505–1512.
Pfeil JN, Rados DV, Roman R, et al. A telemedicine strategy to reduce waiting lists and time to specialist care: a retrospective cohort study. J Telemed Telecare . 2023;29:10–17.
Luna PC, Debernardi ME, Echeverria CM, et al. ECHO project in atopic dermatitis in Argentina: an innovative strategy to reach underserved areas with up to date knowledge, first year of experience. An Bras Dermatol . 2022;97:443–447.
Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med . 2017;377:1585–1592.
LeRouge CM, Gupta M, Corpart G, et al. Health system approaches are needed to expand telemedicine use across nine Latin American nations. Health Aff (Millwood) . 2019;38:212–221.
Rodrigues RJ, Risk A. eHealth in Latin America and the Caribbean: development and policy issues. J Med Internet Res . 2003;5:e4.
Boxer RJ, Ellimoottil C. Advantages and utilization of telemedicine. Mhealth . 2019;5:12.
Gajarawala SN, Pelkowski JN. Telehealth benefits and barriers. J Nurse Pract . 2021;17:218–221.
Belvis R, Santos-Lasaosa S, Irimia P, et al. Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group. Neurologia (Engl Ed) . 2021.
Fernandez-Avila DG, Barahona-Correa J, Romero-Alvernia D, et al. Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America. Rheumatol Int . 2022;42:41–49.
Fernandez-Avila DG, Barahona-Correa J, Romero-Alvernia D, et al. Impact of COVID-19 pandemic on rheumatology practice in Latin America. J Rheumatol . 2021;48:1616–1622.
Cortés JC, AMP Velandia, LJS Cajas, et al. Satisfacción del servicio de telemedicina en pacientes con artritis reumatoide. Rev Colombiana Reumatol . 2021. doi:10.1016/j.rcreu.2021.09.005. (PMID: 10.1016/j.rcreu.2021.09.005)
Mobarak AM, Saldanha NA. Remove barriers to technology adoption for people in poverty. Nat Hum Behav . 2022;6:480–482.
Parente SL, Prescott EC. Barriers to technology adoption and development. J Polit Econ . 1994;102:298–321.
Budd J, Miller BS, Manning EM, et al. Digital technologies in the public-health response to COVID-19. Nat Med . 2020;26:1183–1192.
Prvu Bettger J, Thoumi A, Marquevich V, et al. COVID-19: maintaining essential rehabilitation services across the care continuum. BMJ Glob Health . 2020;5:e002670.
Scott Kruse C, Karem P, Shifflett K, et al. Evaluating barriers to adopting telemedicine worldwide: a systematic review. J Telemed Telecare . 2018;24:4–12.
Rudin RS, Auerbach D, Zaydman M, et al. Paying for telemedicine. Am J Manag Care . 2014;20:983–985.
Russo JE, McCool RR, Davies L. VA telemedicine: an analysis of cost and time savings. Telemed J E Health . 2016;22:209–215.
Xie Z, Chen J, Or CK. Consumers' willingness to pay for eHealth and its influencing factors: systematic review and meta-analysis. J Med Internet Res . 2022;24:e25959.
Cavagna L, Zanframundo G, Codullo V, et al. Telemedicine in rheumatology: a reliable approach beyond the pandemic. Rheumatology (Oxford) . 2021;60:366–370.
National Technical Reports Library. | Innovation, demand and investment in telehealth. Available at: https://ntrl.ntis.gov/NTRL/dashboard/searchResults/titleDetail/PB2004105425.xhtml . Accessed September 17, 2018.
Bender W, Hiddleson CA, Buchman TG. Intensive care unit telemedicine: innovations and limitations. Crit Care Clin . 2019;35:497–509.
LeRouge C, Garfield MJ. Crossing the telemedicine chasm: have the U.S. barriers to widespread adoption of telemedicine been significantly reduced? Int J Environ Res Public Health . 2013;10:6472–6484.
Reconciling disparate nformation in continuity of care documents: piloting a system to consolidate structured clinical documents. J Biomed Inform . 2017;74:123–129.
Kuziemsky CE, Gogia SB, Househ M, et al. Balancing health information exchange and privacy governance from a patient-centred connected health and telehealth perspective. Yearb Med Inform . 2018;27:48–54.
Grainger R, Townsley H, White B, et al. Apps for people with rheumatoid arthritis to monitor their disease activity: a review of apps for best practice and quality. JMIR Mhealth Uhealth . 2017;5:e7.
Bateman J, Cleaton N. Managing patients using telerheumatology: lessons from a pandemic. Best Pract Res Clin Rheumatol . 2021;35:101662.
Keesara S, Jonas A, Schulman K. COVID-19 and health care's digital revolution. N Engl J Med . 2020;382:e82.
McLean TR. The future of telemedicine & its Faustian reliance on regulatory trade barriers for protection. Health Matrix Clevel . 2006;16:443–509.
Solimini R, Busardo FP, Gibelli F, et al. Ethical and legal challenges of telemedicine in the era of the COVID-19 pandemic. Medicina (Kaunas) . 2021;57.
Nittari G, Khuman R, Baldoni S, et al. Telemedicine practice: review of the current ethical and legal challenges. Telemed J E Health . 2020;26:1427–1437.
Kaplan B. Revisiting health information technology ethical, legal, and social issues and evaluation: telehealth/telemedicine and COVID-19. Int J Med Inform . 2020;143:104239.
Fontaine P, Ross SE, Zink T, et al. Systematic review of health information exchange in primary care practices. J Am Board Fam Med . 2010;23:655–670.
Kumar G, Falk DM, Bonello RS, et al. The costs of critical care telemedicine programs: a systematic review and analysis. Chest . 2013;143:19–29.
Jang-Jaccard J, Nepal S, Alem L, et al. Barriers for delivering telehealth in rural Australia: a review based on australian trials and studies. Telemed J E Health . 2014;20:496–504.
Moehr JR, Schaafsma J, Anglin C, et al. Success factors for telehealth—a case study. Int J Med Inform . 2006;75:755–763.
Bodine CD, Das DG, Haywood K, et al. Barriers to telehealth: the patient perspective. J Clin Oncol . 2020;38:266–266.
Kahn JM, Rak KJ, Kuza CC, et al. Determinants of intensive care unit telemedicine effectiveness. An ethnographic study. Am J Respir Crit Care Med . 2019;199:970–979.
Avdalovic MV, Marcin JP. When will telemedicine appear in the ICU? J Intensive Care Med . 2019;34:271–276.
Deslich S, Coustasse A. Expanding technology in the ICU: the case for the utilization of telemedicine. Telemed J E Health . 2014;20:485–492.
Matsumoto RA, England BR, Mastarone G, et al. Rheumatology clinicians' perceptions of telerheumatology within the Veterans Health Administration: a national survey study. Mil Med . 2020;185:e2082–e2087.
McDougall JA, Ferucci ED, Glover J, et al. Telerheumatology: a systematic review. Arthritis Care Res (Hoboken) . 2017;69:1546–1557.
de Thurah A, Stengaard-Pedersen K, Axelsen M, et al. Tele-health followup strategy for tight control of disease activity in rheumatoid arthritis: results of a randomized controlled trial. Arthritis Care Res (Hoboken) . 2018;70:353–360.
Kulcsar Z, Albert D, Ercolano E, et al. Telerheumatology: a technology appropriate for virtually all. Semin Arthritis Rheum . 2016;46:380–385.
Gkrouzman E, Wu DD, Jethwa H, et al. Telemedicine in rheumatology at the advent of the COVID-19 pandemic. HSS J . 2020;16:108–111.
Mann DM, Chen J, Chunara R, et al. COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc . 2020;27:1132–1135.
Huang JA, Hartanti IR, Colin MN, et al. Telemedicine and artificial intelligence to support self-isolation of COVID-19 patients: recent updates and challenges. Digit Health . 2022;8:20552076221100634.
Schünke LC, Mello B, da Costa CA, et al. A rapid review of machine learning approaches for telemedicine in the scope of COVID-19. Artif Intell Med . 2022;129:102312.
EBS Sloane, Silva R. Artificial intelligence in medical devices and clinical decision support systems. Clin Eng Handb . 2020;556–568. doi:10.1016/B978-0-12-813467-2.00084-5. (PMID: 10.1016/B978-0-12-813467-2.00084-5)
Abbass HA. Social integration of artificial intelligence: functions, automation allocation logic and human-autonomy trust. Cogn Comput . 2019;11:159–171.
Pacis DMM, Subido EDC Jr., Bugtai NT. Trends in telemedicine utilizing artificial intelligence. AIP Conf Proc . 1933;040009:2018.
Nangalia V, Prytherch DR, Smith GB. Health technology assessment review: remote monitoring of vital signs—current status and future challenges. Crit Care . 2010;14:233.
Salaffi F, Carotti M, Ciapetti A, et al. Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with the conventional management approach. BMC Musculoskelet Disord . 2016;17:146.
Pouls BPH, Bekker CL, Gaffo AL, et al. Tele-monitoring flares using a smartphone app in patients with gout or suspected gout: a feasibility study. Rheumatol Adv Pract . 2021;5:rkab100.
FDA Clears First Autonomous Telemedicine Robot for Hospitals. January 24, 2013. Available at: http://www.businesswire.com/news/home/20130124005134/en/FDA-Clears-Autonomous-Telemedicine . Accessed August 7, 2022.
Choudary S. Dr Rho - Medical Telepresence Robot: Create the Future Design Contest. July 2, 2014. Available at: https://contest.techbriefs.com/2014/entries/medical/5078 . Accessed August 7, 2022.
Kazantsev AP J, Kazantsev P, Digilov R, et al. Development of e-health network for in-home pregnancy surveillance based on artificial intelligence. In: Proceedings of 2012 IEEE-EMBS International Conference on Biomedical and Health Informatics . IEEE; 2012. p. 82–84.
AiCure-The link between patients, disease and treatment. Available at: https://aicure.com/ . Accessed August 7, 2022.
Alder H, Marx C, Steurer J, et al. RheumaTool, a novel clinical decision support system for the diagnosis of rheumatic diseases, and its first validation in a retrospective chart analysis. Swiss Med Wkly . 2020;150:w20369.
Knitza J, Tascilar K, Gruber E, et al. Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students. Arthritis Res Ther . 2021;23:233.
Wood PR, Caplan L. Outcomes, satisfaction, and costs of a rheumatology telemedicine program: a longitudinal evaluation. J Clin Rheumatol . 2019;25:41–44.
Ryu S. Telemedicine: opportunities and developments in member states: report on the Second Global Survey on eHealth 2009 (Global Observatory for eHealth Series, Volume 2). Healthc Inform Res . 2012;18:153–155.
Dias D, Paulo Silva Cunha J. Wearable health devices—vital sign monitoring, systems and technologies. Sensors (Basel) . 2018;18:2414.
Hugle M, Omoumi P, van Laar JM, et al. Applied machine learning and artificial intelligence in rheumatology. Rheumatol Adv Pract . 2020;4:rkaa005.
McMaster C, Bird A, Liew DFL, et al. Artificial intelligence and deep learning for rheumatologists. Arthritis Rheumatol . 2022;74:1893–1905.
Stoel B. Use of artificial intelligence in imaging in rheumatology—current status and future perspectives. RMD Open . 2020;6:e001063.
تواريخ الأحداث: Date Created: 20230324 Date Completed: 20230327 Latest Revision: 20230927
رمز التحديث: 20230928
DOI: 10.1097/RHU.0000000000001968
PMID: 36959199
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-7355
DOI:10.1097/RHU.0000000000001968